Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents
In Her2-positive breast cancer patients, inhibition of epidermal growth factor receptor 2 (ErbB2)-signaling is often combined with chemotherapy and radiotherapy. The risk of cardiac toxicity after anthracyclines and radiotherapy is recognized, but little is known about increased risk when these trea...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824562/ |